InVitro International
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVRO research report →
Price Chart
About the company
Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining chemical corrosiveness.
- CEO
- W. Richard Ulmer
- IPO
- 1991
- Employees
- 5
- HQ
- Placentia, CA, US
Get TickerSpark's AI analysis on IVRO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.34M
- P/E
- 17.14
- PEG
- -0.50
- P/S
- 1.73
- P/B
- 0.78
- EV/EBITDA
- 6.57
- Div Yield
- 0.00%
- Gross Margin
- 81.88%
- Op Margin
- 4.45%
- Net Margin
- 8.18%
- ROE
- 3.76%
- ROIC
- 1.70%
Latest fiscal year · YoY change
- Revenue
- $878.94K+8.3%
- Gross Profit
- $718.09K+9.9%
- Op Income
- $87.02K
- Net Income
- $121.98K+14.3%
- EPS
- $0.01+14.9%
- OCF Growth
- -107.4%
- FCF Growth
- -108.8%
- 52W High
- $0.16
- 52W Low
- $0.03
- 50D MA
- $0.07
- 200D MA
- $0.08
- Beta
- -0.83
- RSI (14)
- 40
- Avg Volume
- 9.46K
No earnings-call transcripts are available for IVRO yet.
- Free Float
- 69.7%
- Shares Outstanding
- 22.26M
- Float Shares
- 15.52M
Our IVRO coverage
Recent articles, reports, and earnings notes.
No research on IVRO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVRO report →A Brighter Future Is on the Way
newsfilecorp.com · Aug 11
Continuing the Cause; Humane Global Animal Welfare
newsfilecorp.com · May 5
InVitro International & the World's Animals Look Forward to 2026
feeds.newsfilecorp.com · Feb 11
Game Changing Signals from Global Regulatory Agencies Accompany IVRO Sales and Profit Gains
newsfilecorp.com · Dec 9
IVRO's Q3 Packed with Positives; Sales, Profits, and U.S. Government/Global Support for Animal Welfare
newsfilecorp.com · Aug 5
IVRO Announces Strong FY '25 First Quarter Sales & Net Income Advances
newsfilecorp.com · Feb 4
IVRO Signs MOU to Merge With a European Based Non-Animal Testing Focused Organization
newsfilecorp.com · Jan 14
InVitro International: Expectations Remain High for Animal Welfare & Growth Opportunities
newsfilecorp.com · Dec 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.